Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Zhiwei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9648-9119; OpenAlex author ID A5114860048. Sources: OpenAlex.

Their work

Papers
7 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 3 papers · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 7

  1. E2F1-Driven WDHD1 Transcription Enhances Cell-Cycle Progression and Promotes Pancreatic Cancer Progression. First author DOI 10.3390/curroncol33040186↗
  2. tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcription. Co-author DOI 10.1038/s41388-024-02991-9↗
  3. Serum PCSK9 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Co-author DOI 10.7717/peerj.18018↗
  4. The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma. Co-author DOI 10.3390/jcm12041398↗
  5. Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/jcm11113101↗
  6. Pancreatic Adenosquamous Carcinoma: A Rare Pathological Subtype of Pancreatic Cancer. First author DOI 10.3390/jcm11247401↗
  7. Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3. First author DOI 10.3390/jcm12010200↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qunli Xiong · 6 shared papers, 2022–2024 · strength 1.19
  2. Yongfeng Xu · 6 shared papers, 2022–2024 · strength 1.19
  3. Qing Zhu · 5 shared papers, 2022–2024 · strength 0.96
  4. Jinlu Liu · 3 shared papers, 2022–2024 · strength 0.49
  5. Ying Zheng · 2 shared papers, 2022–2024 · strength 0.34
  6. Qing Zhu · 1 shared paper, 2026 · strength 0.33
  7. Xiaojuan Yang · 1 shared paper, 2026 · strength 0.33
  8. Ying Cao Xu · 1 shared paper, 2024 · strength 0.26
  9. Qing Zhu · 1 shared paper, 2022 · strength 0.22
  10. Zhu Zeng · 1 shared paper, 2024 · strength 0.18
  11. Ningna Weng · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.